Download the Schwab app from iTunes®Get the AppClose

Health Care Sector Rating: Outperform

What is the health care sector?

It includes hospitals, health maintenance organizations (HMOs), health care technology and equipment, as well as pharmaceutical and biotechnology companies.

The Health Care sector has many positives, including an aging global population and a growing middle class in emerging markets, all of whom will demand more extensive drug treatments and medical care over time. Meanwhile, balance sheets in the Health Care sector remain flush with cash, increasing the possibility of higher dividend payments, share-enhancing stock buybacks, and mergers and acquisitions. 

On the other hand, health care reform probably will be a focus during the run up to the 2020 elections, prompting volatility to increase. Proposals to cut costs, which could weigh on providers’ profitability, may come from both sides of the political aisle. 

In general, we believe the risk of major legislative changes is relatively low. Potential changes under discussion are well known, and probably already reflected in stock prices. Even after strong relative returns in recent months, we can see this in the current discount to the overall market in numerous valuation metrics; the sector has generally traded at a premium to the market over the past 20 years. 

The durability of Health Care sector earnings during economic downturns tends to lead to outperformance during periods of economic weakness, but we think that solid fundamentals, strong momentum and attractive relative valuations can lead to outperformance in a moderate growth environment, as well. 

We believe an outperform rating for the entire sector is appropriate.

Sector Overview: Health Care is positive on Value and Relative Strength

Note: Each of the sector lenses shown above—Macroeconomic, Value, Fundamental and Relative Strength—is both intuitive and evidenced-based in nature. Within each, there are a varying number of factors. The Macroeconomic lens includes sector sensitivities to interest rates, stocks and the value of the U.S. dollar; the outlook for each of these is determined by the Schwab Center for Financial Research (SCFR)’s Asset Allocation Working Group, which uses a mosaic approach of quantitative and qualitative considerations. Value includes six different valuation metrics that provide a holistic perspective on current valuations relative to each of the sectors’ own historical valuations, as well as relative to the other sectors. Fundamental provides insight as to how efficiently the companies within each sector use invested capital to produce earnings; this historically has been informative as to future relative performance of the sectors. Finally, Relative Strength measures momentum of the individual sectors against all of the other sectors. We also consider the data in the context of factors outside the scope of these indicators—for example, geopolitical risk or anticipated tax legislation.   

Source: Charles Schwab, as of 01/23/2020.

What do the ratings mean?

The sectors we analyze are from the widely recognized Global Industry Classification Standard (GICS®) groupings. After a review of risks and opportunities, we give each stock sector one of the following ratings:

  • Outperform: likely to perform better than the broader stock market*
  • Underperform: likely to perform worse than the broader stock market
  • Marketperform: likely to track the broader stock market

 

Want to learn more about a specific sector?  Click on a link below for more information or visit Schwab Sector Views to see how they compare. Clients can log in to see our top-rated stocks in the Health Care sector.

 

* As represented by the S&P 500 index

Communication Services Industrials
Consumer Discretionary Information Technology
Consumer Staples Materials
Energy Real Estate
Financials Utilities

 

What You Can Do Next

 

Communication Services Sector Rating: Marketperform
Energy Sector Rating: Marketperform

Important Disclosures

Schwab Sector Views do not represent a personalized recommendation of a particular investment strategy to you. You should not buy or sell an investment without first considering whether it is appropriate for you and your portfolio. Additionally, you should review and consider any recent market news. Supporting documentation for any claims or statistical information is available upon request.

All expressions of opinion are subject to change without notice in reaction to shifting market or other conditions. Data contained herein from third-party providers is obtained from what are considered reliable sources. However, its accuracy, completeness or reliability cannot be guaranteed.

The policy analysis provided by the Charles Schwab & Co., Inc., does not constitute and should not be interpreted as an endorsement of any political party.

Indexes are unmanaged, do not incur management fees, costs and expenses and cannot be invested in directly. For more information on indexes please see www.schwab.com/indexdefinitions.

Past performance is no guarantee of future results and the opinions presented cannot be viewed as an indicator of future performance.

Investing involves risk including loss of principal.

The Schwab Center for Financial Research is a division of Charles Schwab & Co., Inc.

(0120-0TFK)

Thumbs up / down votes are submitted voluntarily by readers and are not meant to suggest the future performance or suitability of any account type, product or service for any particular reader and may not be representative of the experience of other readers. When displayed, thumbs up / down vote counts represent whether people found the content helpful or not helpful and are not intended as a testimonial. Any written feedback or comments collected on this page will not be published. Charles Schwab & Co., Inc. may in its sole discretion re-set the vote count to zero, remove votes appearing to be generated by robots or scripts, or remove the modules used to collect feedback and votes.